Kristian Berg Selected Research

di(4-sulfonatophenyl)diphenylporphine

4/2012	Strongly amphiphilic photosensitizers are not substrates of the cancer stem cell marker ABCG2 and provides specific and efficient light-triggered drug delivery of an EGFR-targeted cytotoxic drug.
6/2008	Photodynamic therapy with an endocytically located photosensitizer cause a rapid activation of the mitogen-activated protein kinases extracellular signal-regulated kinase, p38, and c-Jun NH2 terminal kinase with opposing effects on cell survival.
11/2006	Photochemical internalization of therapeutic macromolecular agents: a novel strategy to kill multidrug-resistant cancer cells.
6/2006	Photochemical treatment with endosomally localized photosensitizers enhances the number of adenoviruses in the nucleus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kristian Berg Research Topics

Disease

68	Neoplasms (Cancer) 01/2022 - 03/2002
13	Glioma (Gliomas) 06/2022 - 04/2012
13	Rupture 02/2020 - 03/2002
8	Breast Neoplasms (Breast Cancer) 01/2022 - 12/2006
8	Carcinoma (Carcinomatosis) 12/2017 - 04/2002
6	Sarcoma (Soft Tissue Sarcoma) 12/2017 - 12/2005
5	Adenocarcinoma 01/2022 - 10/2006
5	Necrosis 02/2020 - 05/2009
4	Glioblastoma (Glioblastoma Multiforme) 07/2020 - 07/2004
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2020 - 03/2013
3	Fibrosarcoma 09/2013 - 11/2006
2	Squamous Cell Carcinoma of Head and Neck 01/2020 - 06/2006
2	Leiomyosarcoma 12/2017 - 12/2017
2	Urinary Bladder Neoplasms (Bladder Cancer) 11/2017 - 03/2015
2	Non-Muscle Invasive Bladder Neoplasms 11/2017 - 03/2015
2	Prostatic Neoplasms (Prostate Cancer) 08/2014 - 07/2003
2	Colonic Neoplasms (Colon Cancer) 01/2014 - 01/2009
2	Photosensitivity Disorders (Photodermatitis) 04/2012 - 04/2005
2	Wounds and Injuries (Trauma) 10/2011 - 06/2009
2	Colorectal Neoplasms (Colorectal Cancer) 11/2006 - 06/2006
2	Infections 06/2006 - 05/2005
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2020
1	Brain Neoplasms (Brain Tumor) 01/2018
1	Hyperthermia 04/2016
1	Fatty Liver 01/2016
1	Fibrosis (Cirrhosis) 01/2016
1	Carcinogenesis 01/2016
1	Porphyrias (Porphyria) 01/2016
1	Ovarian Neoplasms (Ovarian Cancer) 05/2015

Drug/Important Bio-Agent (IBA)

32	Photosensitizing Agents (Photosensitizers)IBA 10/2021 - 03/2002
30	1-phenyl-3,3-dimethyltriazene (PDT)IBA 07/2021 - 01/2005
17	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022 - 12/2005
17	Pharmaceutical PreparationsIBA 07/2021 - 01/2004
5	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018 - 06/2008
5	Immunotoxins (Immunotoxin)IBA 08/2015 - 03/2007
5	SaporinsIBA 09/2013 - 03/2006
4	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2022 - 12/2006
4	ProdrugsIBA 03/2021 - 07/2004
4	PorphyrinsIBA 04/2015 - 04/2005
4	di(4-sulfonatophenyl)diphenylporphineIBA 04/2012 - 06/2006
4	Proteins (Proteins, Gene)FDA Link 10/2011 - 03/2006
3	Fluorouracil (Carac)FDA LinkGeneric 03/2021 - 04/2016
3	Therapeutic UsesIBA 01/2020 - 05/2009
3	Cetuximab (Erbitux)FDA Link 01/2020 - 03/2007
3	ErbB Receptors (EGF Receptor)IBA 01/2020 - 03/2006
3	Cytosine DeaminaseIBA 01/2019 - 01/2014
3	DNA (Deoxyribonucleic Acid)IBA 10/2017 - 12/2004
3	chlorinIBA 09/2016 - 10/2011
3	Gelonium multiflorum GEL proteinIBA 12/2013 - 03/2010
3	tetraphenylporphineIBA 04/2012 - 10/2006
2	VaccinesIBA 06/2022 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 11/2021 - 07/2020
2	Trastuzumab (Herceptin)FDA Link 11/2021 - 05/2015
2	EnzymesIBA 03/2021 - 12/2017
2	protoporphyrin IXIBA 07/2020 - 12/2005
2	cercosporinIBA 01/2020 - 01/2019
2	phthalocyanineIBA 01/2020 - 06/2009
2	Caspase 3 (Caspase-3)IBA 01/2020 - 05/2015
2	LipidsIBA 01/2020 - 04/2002
2	Flucytosine (Ancobon)FDA Link 01/2019 - 05/2014
2	Estrogen ReceptorsIBA 01/2019 - 01/2016
2	Oxygen (Dioxygen)IBA 01/2018 - 07/2011
2	NanoconjugatesIBA 10/2017 - 04/2015
2	Tamoxifen FDA LinkGeneric 01/2016 - 04/2015
2	bisbenzimide ethoxide trihydrochloride (Hoechst 33342)IBA 01/2014 - 04/2012
2	AluminumIBA 04/2012 - 06/2009
2	Biological ProductsIBA 11/2010 - 03/2002
2	Epidermal Growth Factor (EGF)IBA 11/2006 - 03/2006
2	AcidsIBA 12/2005 - 04/2005
1	HMGB1 Protein (HMG1)IBA 06/2022
1	Ado-Trastuzumab EmtansineIBA 11/2021
1	Paclitaxel (Taxol)FDA LinkGeneric 11/2021
1	pertuzumabIBA 11/2021
1	Sunitinib (Sutent)FDA Link 02/2020
1	IronIBA 01/2020
1	Gemcitabine FDA Link 01/2020
1	Silicon Dioxide (Silica)FDA LinkGeneric 11/2018
1	GoldIBA 11/2018
1	GalactosidasesIBA 12/2017
1	AntioxidantsIBA 12/2017
1	pheophorbide aIBA 11/2017
1	hypericinIBA 01/2017
1	mahuang-tangIBA 04/2016
1	Tyrosine Kinase InhibitorsIBA 08/2015
1	Epithelial Cell Adhesion MoleculeIBA 08/2015
1	Monoclonal AntibodiesIBA 08/2015
1	Temozolomide (Temodar)FDA LinkGeneric 07/2015
1	meso-tetraphenyl chlorin disulphonateIBA 07/2015
1	tetra(3-hydroxyphenyl)porphineIBA 04/2015
1	CyclodextrinsIBA 04/2015

Therapy/Procedure

33	Therapeutics 03/2021 - 03/2002
27	Photochemotherapy (Photodynamic Therapy) 07/2020 - 03/2002
6	Drug Therapy (Chemotherapy) 01/2022 - 12/2005
2	Radiotherapy 08/2015 - 11/2009
1	Lasers (Laser) 01/2020
1	Oral Administration 01/2018
1	Semiconductor Lasers 12/2017
1	Intravesical Administration 11/2017
1	Catheters 11/2017
1	Molecular Targeted Therapy 08/2015